AstraZeneca PLC Annual Financial Report
February 20 2024 - 5:00AM
RNS Regulatory News
RNS Number : 7706D
AstraZeneca PLC
20 February 2024
20 February 2024 11:00
GMT
Annual Financial
Report
AstraZeneca PLC (the Company)
announced today the publication of its Annual Report and Form 20-F
Information 2023 (the Annual Report).
A copy of the Annual Report will be
submitted to the National Storage Mechanism and will shortly be
available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The Annual Report is also available
on the Company's website www.astrazeneca.com.
The Annual Report will be dispatched
to shareholders in due course.
The Company's Annual General Meeting
(AGM) will take place on 11 April 2024. The Notice of AGM and
Shareholders' Circular will be published and distributed to
shareholders in due course.
EXPLANATORY NOTE
For the purposes of complying with
the Disclosure and Transparency Rules, the Annual Report being
submitted to the National Storage Mechanism contains the following
regulated information in unedited form:
- the
principal risks and uncertainties facing the
Company;
|
- the
Directors' responsibility statement made in respect of the
Financial Statements and Directors' Report contained in the Annual
Report; and
|
- a
statement regarding related party transactions.
|
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global,
science-led biopharmaceutical company that focuses on the
discovery, development, and commercialisation of prescription
medicines in Oncology, Rare Diseases, and BioPharmaceuticals,
including Cardiovascular, Renal & Metabolism, and Respiratory
& Immunology. Based in Cambridge, UK, AstraZeneca operates in
over 100 countries and its innovative medicines are used by
millions of patients worldwide. Please visit astrazeneca.com and
follow the Company on social media @AstraZeneca.
Contacts
For details on how to contact the
Investor Relations Team, please click here.
For Media contacts, click here.
Adrian Kemp
Company Secretary
AstraZeneca PLC
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
ACSPPUBGPUPCUBU
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Apr 2024 to May 2024
Astrazeneca (LSE:AZN)
Historical Stock Chart
From May 2023 to May 2024